Elixinol Wellness Limited (ASX:EXL)
Australia
· Delayed Price · Currency is AUD 0.0190
-0.0030 (-13.64%)
Apr 29, 2025, 3:55 PM AEST
Elixinol Wellness Revenue
In the year 2024, Elixinol Wellness had annual revenue of 14.96M AUD with 80.87% growth. Elixinol Wellness had revenue of 8.18M in the half year ending December 31, 2024, with 113.18% growth.
Revenue
14.96M
Revenue Growth
+80.87%
P/S Ratio
0.28
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.20M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Mesoblast | 9.16M |
Elixinol Wellness News
- 21 days ago - Marijuana Stock Movers For April 7, 2025 - Benzinga
- 7 weeks ago - Cannabis Stock Movers For March 10, 2025 - Benzinga
- 7 months ago - Marijuana Stock Movers For October 11, 2024 - Benzinga
- 7 months ago - Cannabis Stock Gainers And Losers From October 1, 2024 - Benzinga
- 7 months ago - Bullish Sentiment Across The Cannabis Space - Check Full Movers For September 23, 2024 - Benzinga
- 7 months ago - Cannabis Stock Movers For September 20, 2024 - Benzinga
- 8 months ago - Cannabis Stock Gainers And Losers From September 5, 2024 - Benzinga
- 1 year ago - Study on the safety of Elixinol Hemp Extract is published in Journal of Toxicology - PRNewsWire